IL-1β Pretreatment Improves the Efficacy of Mesenchymal Stem Cells on Acute Liver Failure by Enhancing CXCR4 Expression

BACKGROUND: Mesenchymal stem cells (MSCs), with the powerful metabolic and functional supporting abilities for inflammatory diseases, may be an effective therapeutic strategy for acute liver failure (ALF). However, the efficacy of MSCs can still be promoted if pretreatment is applied to enhance thei...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, He, An, Fangmei, Mei, Jie, Yang, Cheng, Zhan, Qiang, Zhang, Qinglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364198/
https://www.ncbi.nlm.nih.gov/pubmed/32724311
http://dx.doi.org/10.1155/2020/1498315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364198/
https://www.ncbi.nlm.nih.gov/pubmed/32724311
http://dx.doi.org/10.1155/2020/1498315

Ejemplares similares